9 February 2026
We are offering a new PostDoc grant to decipher the role of lymphatic dysfunction in chronic lung diseases such as pulmonary fibrosis (PF) and chronic obstructive pulmonary disease (COPD). This unique opportunity allows highly talented scientists to pursue their own postdoctoral research proposal within the cutting-edge immunology and respiratory research environment at Boehringer Ingelheim in Biberach/Riss, Germany.
Lymphatic vessels play a critical yet underexplored role in maintaining lung health by regulating fluid balance and immune responses. Current research aims to understand how lymphatic microvascular networks remodel over time, interact with epithelial, immune, and stromal cells, and influence inflammation and edema. Particular attention is given to the alveolar region of the lung, the primary site of gas exchange and a key driver of lung function.
This PostDoc grant offers the opportunity for researchers to focus on investigating lymphatic microvascular dysfunction in PF and COPD endotypes, with the goal of uncovering mechanistic insights and identifying translational biomarkers through the use of fresh human lung tissue samples.
To apply for this grant, formulate a research project that answers the following question:
How would you propose to decipher the role of lymphatic dysfunction in chronic lung diseases, using relevant complex human in vitro models?
Should your submission become accepted, you will work as part of an international team of highly skilled scientists focusing on lung diseases and gain valuable insights into the drug discovery process in the pharmaceutical industry. Additionally, you will have the opportunity to receive expert mentoring, attend prestigious international conferences, and publish your research in high-impact journals.
Please submit your complete application package, including your project plan, CV, publication list, and recommendation to become eligible for this call. All applications that arrive through March 10, 2026, 11:59 pm PST will receive a review of our scientific expert team.
Subscribe to our newsletter to stay updated as we add new molecules to opnMe.com.
About our opn2TALENTS program:
Would you like to advance your research career as a PostDoc in the field of cellular and molecular biology at one of the leading pharmaceutical companies? Benefit from a fully funding position and access a fully resourced and state-of-the-art research environment? With defined scientific questions such as the one for this opn2TALENTS call, we provide a unique opportunity for high class talents to pitch their scientific ideas for a well-defined research question. The winner will have the opportunity to execute his/her postdoctoral research at Boehringer Ingelheim. The grant is for a duration of two years, with the possibility of a one-year extension.
About opnMe:
opnMe.com, the open innovation portal of Boehringer Ingelheim, fosters science and collaboration initiatives in areas of high unmet medical need. As part of our “Molecules to Order” pillar, we share well-characterized tool compounds free of charge with no IP strings attached. With our current “opn2EXPERTS” call on the role of TLR5 in tumor immune evasion, we enlist scientific advice on key biologic issues to fuel further drug discovery and deliver novel solutions that benefit unmet patient needs.